
1. Technology overview
Ingenta Inc. is a company headquartered in Roppongi, Tokyo, with a Silicon Valley address, established in June 2018. It builds AI software for pharmaceutical and biomedical research that integrates scattered papers, patents and internal documents.
Research Navi is a Graph RAG AI platform that unifies papers, patents, internal reports, experiment data and LIMS or in-house databases into a knowledge graph. It supports hypothesis exploration, literature review and evidence checking, and shows the reasoning as a graph with source references. It is offered as a full-cloud or an isolated local-server deployment.
2. Highlighted features & specifications
- Semantic understanding: answers that account for domain terms and context.
- Synthesis exploration: integrates tens of thousands of papers and internal data to explore new hypotheses.
- Evidence trace: visualizes the reasoning path as a graph with cited sources.
- Multi-dimensional edge search: explores relations among diseases, genes, proteins, cells and drugs.
- Context weighting: treats paper reliability and data reproducibility as relation weights.
- Deployment options: full cloud or an isolated local-server configuration.
3. Potential application
A pharmaceutical R&D department reviewing literature and internal reports before choosing a drug target. A biotech start-up investigating cell culture conditions across past experiments. A university lab consolidating papers and lab records for research meetings.
4. Benefits
Traces each answer back to the papers and internal documents it came from. Keeps documents in a Tokyo-region cloud segregated per organization, and input data is not used for model training. The site reports a case where MSC culture condition review fell from three weeks to three days (internal PoC result).
5. Market trends & opportunities
Pharma and biotech R&D teams face fast-growing literature and siloed internal data, and are adopting retrieval-augmented generation with traceable evidence. Closed or on-premises deployment matters for confidential research data. Vietnamese pharmaceutical firms and university labs building up research programs could use evidence-linked literature tools.
6. Other information
Ingenta Inc., Roppongi, Tokyo, established June 2018 (per PR TIMES profile). Research Navi received a 2026 Good Design Award; cloud PoC applications opened on 2026-11-02 for up to five organizations, with a subscription release planned for 2027.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































